Zullo Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-355
Closed -$206K 166
2025
Q4
$206K Buy
+355
New +$201K 0.08% 149
2024
Q4
Sell
-399
Closed -$247K 155
2024
Q3
$247K Sell
399
-22
-5% -$13K 0.1% 135
2024
Q2
$233K Sell
421
-2
-0.5% -$1.15K 0.1% 136
2024
Q1
$246K Buy
423
+6
+1% +$3.37K 0.12% 136
2023
Q4
$221K Buy
417
+14
+3% +$6.78K 0.11% 134
2023
Q3
$204K Buy
403
+2
+0.5% +$1.07K 0.12% 131
2023
Q2
$209K Buy
401
+1
+0.3% +$540 0.12% 132
2023
Q1
$231K Buy
400
+2
+0.5% +$1.13K 0.14% 122
2022
Q4
$219K Buy
398
+3
+0.8% +$1.59K 0.13% 123
2022
Q3
$200K Buy
395
+9
+2% +$5.04K 0.13% 130
2022
Q2
$210K Hold
386
0.13% 131
2022
Q1
$228K Buy
386
+2
+0.5% +$1.15K 0.12% 140
2021
Q4
$256K Buy
+384
New +$240K 0.13% 135

Other funds holding TMO

Zullo Investment Group's TMO Position: Q1 2026 in Review

Zullo Investment Group sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 355 shares — an estimated $206K sold.

Zullo Investment Group first reported a position in TMO in Q4 2021 and held it in 13 quarters. The position peaked at $256K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Zullo Investment Group reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Zullo Investment Group sold 355 Thermo Fisher Scientific shares in Q1 2026, an estimated $206K.
  • Zullo Investment Group first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 13 quarters.
  • Zullo Investment Group's Thermo Fisher Scientific position peaked at $256K in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Zullo Investment Group's 13F filing for Q1 2026, filed 15 Apr 2026.